US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MAIA Biotechnology Inc.

2.00

-0.1000-4.76%

Volume:58.93K

Turnover:116.97K

Market Cap:59.17M

PE:-1.91

High:2.04

Open:2.02

Low:1.95

Close:2.10

Loading ...

Overview Company News Filings

Maia Biotechnology Announces Clinical Supply Agreement With Beigene for Upcoming Phase 2 Trials in Three Cancer Indications

THOMSON REUTERS

MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications

BRIEF-MAIA Biotechnology Increased Maximum Offering Price Of Shares Of Common Stock Issuable Under At Market Offering Agreement To $30 Million

Maia Biotechnology : Increased Maximum Offering Price of Shares of Common Stock Issuable Under at Market Offering Agreement to $30 Mln

THOMSON REUTERS

Maia Biotechnology Announces Director Participation in Recent Private Placement Closings

THOMSON REUTERS

MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings

Sector Update: Health Care Stocks Slide Late Afternoon

MT Newswires Live

Sector Update: Health Care Stocks Decline Monday Afternoon

MT Newswires Live

MAIA Biotechnology granted FDA rare pediatric disease designation for THIO

MAIA Biotechnology's THIO Gets US FDA Rare Pediatric Disease Designation to Treat Pediatric High-Grade Gliomas

MT Newswires Live

Maia Biotechnology Granted FDA Rare Pediatric Disease Designation for Thio as a Treatment for Pediatric High-Grade Gliomas

THOMSON REUTERS

MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas

MAIA Biotechnology to sell 507,364 shares at $1.872 in private placement

Maia Biotechnology Announces Private Placement of Approximately $950,000

THOMSON REUTERS

MAIA Biotechnology Announces Private Placement of Approximately $950,000

Amazon Bedrock Empowers Customers to Accelerate Generative AI Adoption with More Than 100 New Models and Powerful New Capabilities for Inference and Working with Data

Maia Biotechnology, Regeneron Expand Clinical Supply Deal

MT Newswires Live

Maia Biotechnology Inc - Expects New Patient Enrollment to Begin Soon

THOMSON REUTERS

Maia Biotechnology Announces Expansion of Clinical Supply Agreement With Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer

THOMSON REUTERS

MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MAIA/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MAIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAIA\",,,,,undefined,":{"symbol":"MAIA","market":"US","secType":"STK","nameCN":"MAIA Biotechnology Inc.","latestPrice":2,"timestamp":1745599440203,"preClose":2.1,"halted":0,"volume":58925,"delay":0,"floatShares":25054078,"shares":29587314,"eps":-1.047624,"marketStatus":"Trading","change":-0.1,"latestTime":"04-25 12:48:59 EDT","open":2.02,"high":2.04,"low":1.95,"amount":116971.49896,"amplitude":0.042857,"askPrice":2.05,"askSize":200,"bidPrice":1.99,"bidSize":311,"shortable":3,"etf":0,"ttmEps":-1.047624,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745611200000},"marketStatusCode":2,"adr":0,"listingDate":1659067200000,"exchange":"AMEX","adjPreClose":2.1,"preHourTrading":{"tag":"盘前","latestPrice":2.04,"preClose":2.1,"latestTime":"09:22 EDT","volume":1044,"amount":2078.0608068,"timestamp":1745587321597},"postHourTrading":{"tag":"盘后","latestPrice":2.02,"preClose":2.1,"latestTime":"19:56 EDT","volume":9569,"amount":19195.6969,"timestamp":1745538995317},"volumeRatio":0.274168},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAIA\",,,,,undefined,":{"symbol":"MAIA","floatShares":25054078,"roa":"-119.60%","roe":"-1131.02%","lyrEps":-1.047624,"volumeRatio":0.274168,"shares":29587314,"dividePrice":0,"high":2.04,"amplitude":0.042857,"preClose":2.1,"low":1.95,"week52Low":1.4,"pbRate":"16.28","week52High":5.99,"institutionHeld":0,"latestPrice":2,"committee":0.217221,"eps":-1.047624,"divideRate":0,"volume":58925,"delay":0,"ttmEps":-1.047624,"open":2.02,"prevYearClose":1.98,"prevWeekClose":1.55,"prevMonthClose":1.53,"prevQuarterClose":1.53,"fiveDayClose":1.55,"twentyDayClose":1.63,"sixtyDayClose":1.83},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAIA\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2501202139","title":"Maia Biotechnology Announces Clinical Supply Agreement With Beigene for Upcoming Phase 2 Trials in Three Cancer Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2501202139","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501202139?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:12","pubTimestamp":1736259120,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nTUA4XMCFN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2501200407","title":"MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2501200407","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501200407?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:12","pubTimestamp":1736259120,"startTime":"0","endTime":"0","summary":"Phase 2 pivotal trials to evaluate efficacy of THIO in combination with BeiGene’s checkpoint inhibitor  tislelizumab. CHICAGO, January 07, 2025----MAIA Biotechnology, Inc.,  , a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into a clinical supply agreement with global oncology company BeiGene to assess the efficacy of THIO, its small molecule telomere-targeting anticancer agent, in combination with BeiGene’s immune checkpoint inhibitor  tislelizumab in three cancer indications. The single arm pivotal Phase 2 trials will study the drug combination in hepatocellular carcinoma , small cell lung cancer  and colorectal cancer .MAIA's preclinical results in HCC, with THIO in combination with a CPI, showed complete, durable and highly potent anti-tumor immune response. Preclinical results of THIO treatment in SCLC showed profound activation of innate and adaptive anti-tumor responses. In CRC pre-clinical studies, T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/maia-biotechnology-announces-clinical-supply-141200167.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CPI","BK4213","LU0053666078.USD","MAIA","LU0266512127.USD","LBRJ","L","LU0456854461.SGD","BK4006","ODD","HCC","BK4585","CRC","BK4588","BK4139","BK4107","BK4183"],"gpt_icon":0},{"id":"2493471442","title":"BRIEF-MAIA Biotechnology Increased Maximum Offering Price Of Shares Of Common Stock Issuable Under At Market Offering Agreement To $30 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2493471442","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493471442?lang=en_us&edition=fundamental","pubTime":"2024-12-24 06:51","pubTimestamp":1734994318,"startTime":"0","endTime":"0","summary":"BRIEF-MAIA Biotechnology Increased Maximum Offering Price Of Shares Of Common Stock Issuable Under At Market Offering Agreement To $30 MillionDec 23  - Maia Biotechnology Inc MAIA.A:MAIA BIOTECHNOLOGY : INCREASED MAXIMUM OFFERING PRICE OF SHARES OF  COMMON STOCK ISSUABLE UNDER AT MARKET OFFERING AGREEMENT TO $30 MILLIONFurther company coverage: MAIA.A ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nFWN3NO0DL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2493714977","title":"Maia Biotechnology : Increased Maximum Offering Price of Shares of  Common Stock Issuable Under at Market Offering Agreement to $30 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2493714977","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493714977?lang=en_us&edition=fundamental","pubTime":"2024-12-24 06:46","pubTimestamp":1734993973,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nFWN3NO0DL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2492017380","title":"Maia Biotechnology Announces Director Participation in Recent Private Placement Closings","url":"https://stock-news.laohu8.com/highlight/detail?id=2492017380","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492017380?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:47","pubTimestamp":1734616020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUA49YFRJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2492617609","title":"MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings","url":"https://stock-news.laohu8.com/highlight/detail?id=2492617609","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492617609?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:47","pubTimestamp":1734616020,"startTime":"0","endTime":"0","summary":"CHICAGO, December 19, 2024----MAIA Biotechnology, Inc.,  , a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that two of the Company’s independent directors, Ramiro Guerrero, JD, LL.M. and Stan V. Smith, Ph.D., purchased MAIA’s common stock and warrants in each of the Company’s recent private placement closings which occurred on November 1, 2024, and December 13, 2024. Total gross proceeds to MAIA from the closings were $3.4 million.Mr. Guerrero purchased a total of 141,952 shares and 141,952 warrants for an aggregate purchase price of approximately $300,000. Dr. Smith purchased a total of 125,000 shares and 125,000 warrants for an aggregate purchase price of approximately $273,000.Mr. Guerrero is the founder and CEO of IMPERIO, Inc., a Chicago-based real estate investment and brokerage organization. In addition to his 20+ years in real estate, Mr. Guerrero is a venture capitalist aiding entrepreneurs and small businesses in busi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/FI4i35Nozp1CEOJz8KcRVQ--~B/aD0zODA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/470604d99b2ca90d7d229e0c8dc53e6e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/FI4i35Nozp1CEOJz8KcRVQ--~B/aD0zODA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/470604d99b2ca90d7d229e0c8dc53e6e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/maia-biotechnology-announces-director-participation-134700311.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","MAIA","BK4107","LU0053666078.USD","L","BK4585","BK4588"],"gpt_icon":0},{"id":"2492647722","title":"Sector Update: Health Care Stocks Slide Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2492647722","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492647722?lang=en_us&edition=fundamental","pubTime":"2024-12-17 05:01","pubTimestamp":1734382877,"startTime":"0","endTime":"0","summary":"Health care stocks declined late Monday afternoon, with the NYSE Health Care Index down 1.1% and the Health Care Select Sector SPDR Fund  falling 1.2%.The iShares Biotechnology ETF  rose 0.6%.In corporate news, Emergent BioSolutions  shares jumped 4.7% after the Biomedical Advanced Research and Development Authority awarded a $50 million option to the company's existing contract for the purchase of Cyfendus.Aspira Women's Health  shares were fractionally up after it said Monday that Chief Executive Nicole Sandford will leave the company due to a family health matter, effective immediately. President Sandra Milligan will serve as interim CEO while the company searches for a permanent successor, the company said.President-elect Donald Trump told reporters his administration is going to \"knock out\" pharmacy benefit managers to bring down drug prices, Bloomberg reported. Shares of CVS Health , UnitedHealth , and Cigna , which own the three largest pharmacy benefit managers, fell 5.6%, 4.5%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1934455277.USD","LU1718418525.SGD","LU0965509101.SGD","IBB","LU2357305700.SGD","AWH","CVS","LU1084165304.USD","LU2461242641.AUD","LU2028103732.USD","LU2360032135.SGD","SG9999018857.SGD","LU0708995401.HKD","IE0002270589.USD","IE00B19Z8W00.USD","CI","IE00BFSS8Q28.SGD","LU0345770308.USD","SG9999001176.SGD","LU2023251221.USD","IE00B19Z3B42.SGD","LU2125154778.USD","LU2552382058.USD","LU1988902786.USD","IE00B19Z8X17.USD","LU2211815571.USD","BK4154","LU1914381329.SGD","LU2361045086.USD","LU0048584097.USD","LU0094547139.USD","CVS.AU","IE00BJJMRZ35.SGD","UNH","LU0943347566.SGD","BK4082","LU2125154935.USD","XLV","LU0353189680.USD","LU1291159041.SGD","SGXZ31699556.SGD","LU0868494617.USD","LU1732800096.USD","MAIA","LU0661504455.SGD","LU0198837287.USD","EBS","LU0053666078.USD","LU1670627923.USD","LU2236285917.USD"],"gpt_icon":1},{"id":"2492081645","title":"Sector Update: Health Care Stocks Decline Monday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2492081645","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492081645?lang=en_us&edition=fundamental","pubTime":"2024-12-17 03:03","pubTimestamp":1734375806,"startTime":"0","endTime":"0","summary":"Health care stocks were lower Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund  each shedding about 0.5%.The iShares Biotechnology ETF  rose 0.9%.In corporate news, President-elect Donald Trump told reporters his administration is going to \"knock out\" pharmacy benefit managers in an effort to bring down drug prices, Bloomberg reported. Shares of UnitedHealth , CVS Health  and Cigna , which own the three largest pharmacy benefit managers, were falling 3.4%, 3.9% and 1.8% respectively.Maia Biotechnology  shares jumped over 8% after the firm said its investigational telomere-targeting agent THIO received a rare pediatric disease designation from the US Food and Drug Administration to treat pediatric-type diffuse high-grade gliomas.Catalent  and Novo Nordisk  said that they have completed all regulatory closing conditions for Novo's pending acquisition of Catalent. Catalent shares rose 0.6%, and Novo added 1.5%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999014906.USD","IE00BN29S564.USD","IE0009355771.USD","LU0310799852.SGD","NVO.AU","LU1037948541.HKD","IE00B19Z9505.USD","LU1074936037.SGD","MAIA","LU2023251221.USD","NVO","LU0353189680.USD","LU1720051017.SGD","LU1066051811.HKD","IE0004445015.USD","CVS","LU0965508806.USD","LU2089283258.USD","BK7104","LU0683600562.USD","LU0545039389.USD","LU0079474960.USD","CI","LU2112291526.USD","LU0114720955.EUR","IE00BJT1NW94.SGD","IE00BWXC8680.SGD","LU0795875169.SGD","LU2087625088.SGD","SGXZ99366536.SGD","LU0097036916.USD","LU2271345857.HKD","IE00BKPKM429.USD","IBB","UNH","IE00B19Z9Z06.USD","LU1506573853.SGD","LU2461242641.AUD","IE00B7SZLL34.SGD","BK4550","LU2468319806.SGD","LU1934455863.HKD","XLV","LU1261432733.SGD","CTLT","CVS.AU","LU0320765489.SGD","LU1093756168.USD","LU1791710582.SGD","LU1066051498.USD"],"gpt_icon":1},{"id":"2492559610","title":"MAIA Biotechnology granted FDA rare pediatric disease designation for THIO","url":"https://stock-news.laohu8.com/highlight/detail?id=2492559610","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492559610?lang=en_us&edition=fundamental","pubTime":"2024-12-17 01:50","pubTimestamp":1734371407,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology (MAIA) earlier announced that the FDA has designated THIO for the treatment of pediatric-type diffuse high-grade gliomas as a dr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-granted-fda-rare-pediatric-disease-designation-for-thio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-granted-fda-rare-pediatric-disease-designation-for-thio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2491924256","title":"MAIA Biotechnology's THIO Gets US FDA Rare Pediatric Disease Designation to Treat Pediatric High-Grade Gliomas","url":"https://stock-news.laohu8.com/highlight/detail?id=2491924256","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491924256?lang=en_us&edition=fundamental","pubTime":"2024-12-16 22:46","pubTimestamp":1734360387,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology  said Monday its investigational telomere-targeting agent THIO received a rare pediatric disease designation from the Food and Drug Administration to treat pediatric-type diffuse high-grade gliomas.The company partnered with Only Orphans Cote for THIO's designation request, it added.MAIA said that THIO is currently in clinical development for evaluating its activity in non-small cell lung cancer.Shares of the company were up 7% in recent Monday trading.Price: 2.14, Change: +0.14, Percent Change: +7.00","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2491696607","title":"Maia Biotechnology Granted FDA Rare Pediatric Disease Designation for Thio as a Treatment for Pediatric High-Grade Gliomas","url":"https://stock-news.laohu8.com/highlight/detail?id=2491696607","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491696607?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:37","pubTimestamp":1734356220,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nTUA11N8GM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2491669462","title":"MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas","url":"https://stock-news.laohu8.com/highlight/detail?id=2491669462","media":"Business Wire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491669462?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:37","pubTimestamp":1734356220,"startTime":"0","endTime":"0","summary":"CHICAGO, December 16, 2024----MAIA Biotechnology, Inc.,  , a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that the FDA has designated THIO for the treatment of pediatric-type diffuse high-grade gliomas  as a drug for a \"rare pediatric disease.\". \"THIO is a versatile anti-cancer agent that has demonstrated positive results in multiple difficult to treat cancer types, including pediatric high-grade glioma, which is among the most treatment-resistant cancers in children. THIO is shown to activate the immune system while evading tumor immunosuppression, a novel therapeutic approach for this devastating childhood disease,\" said MAIA Chairman and Chief Executive Officer Vlad Vitoc, M.D. \"We are proud to receive the FDA’s Rare Pediatric Disease designation for THIO, which significantly bolsters our plans for continuing research in the PDHGG indication.\". Rare pediatric disease priority review vouchers  can be redeemed by drug develop","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/o8xjZukNIGQajn16aQeq6Q--~B/aD0zODA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/a7941b4347fd25daca568f9a4279bf12","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/o8xjZukNIGQajn16aQeq6Q--~B/aD0zODA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/a7941b4347fd25daca568f9a4279bf12"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/maia-biotechnology-granted-fda-rare-133700877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4161","BK4107","LU0256863811.USD","ODD","BK4139","LU0256863902.USD","L","BK4006","MAIA","LU1978683503.SGD","BK4585","HCC","IR","LU0053666078.USD","LU0124384867.USD","LU0417517546.SGD","BK4588","SG9999001440.SGD","BK4183"],"gpt_icon":0},{"id":"2490825560","title":"MAIA Biotechnology to sell 507,364 shares at $1.872 in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2490825560","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490825560?lang=en_us&edition=fundamental","pubTime":"2024-12-10 07:05","pubTimestamp":1733785528,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology (MAIA) announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 507,364 shares of c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-to-sell-507364-shares-at-1-872-in-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maia-biotechnology-to-sell-507364-shares-at-1-872-in-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2490084469","title":"Maia Biotechnology Announces Private Placement of Approximately $950,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2490084469","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490084469?lang=en_us&edition=fundamental","pubTime":"2024-12-10 07:00","pubTimestamp":1733785200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nTUA3QCQWH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"gpt_icon":0},{"id":"2490847790","title":"MAIA Biotechnology Announces Private Placement of Approximately $950,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2490847790","media":"Business Wire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490847790?lang=en_us&edition=fundamental","pubTime":"2024-12-10 07:00","pubTimestamp":1733785200,"startTime":"0","endTime":"0","summary":"CHICAGO, December 09, 2024----MAIA Biotechnology, Inc.,  , a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 507,364 shares of common stock at a purchase price of $1.872 per share, in a private placement to accredited investors and certain Company directors. Each share of common stock is being offered together with a warrant to purchase one share of common stock at an exercise price of $2.08 per share, which price represents the greater of the book or market value of the stock on the date the definitive agreements were executed . The warrants are exercisable commencing six months following issuance and have a term of five years from the initial exercise date. The securities being sold to the Company director participating in the offering are being issued pursuant to the Company’s 2021 Equity Incentive Plan. The private placement is expecte","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ORokj0OMHn_g4k1i0Iutbw--~B/aD0zODA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/2bea094b19ef8a8d7f57d4c64f29ae76","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ORokj0OMHn_g4k1i0Iutbw--~B/aD0zODA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/2bea094b19ef8a8d7f57d4c64f29ae76"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/maia-biotechnology-announces-private-placement-230000083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2489143999","title":"Amazon Bedrock Empowers Customers to Accelerate Generative AI Adoption with More Than 100 New Models and Powerful New Capabilities for Inference and Working with Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2489143999","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489143999?lang=en_us&edition=fundamental","pubTime":"2024-12-05 01:54","pubTimestamp":1733334840,"startTime":"0","endTime":"0","summary":"Discover Amazon Bedrock Marketplace models and Amazon Bedrock fully managed models in the new model catalog . The biggest expansion of models to date, new inference optimization tools, and additional data capabilities give customers even greater flexibility and control to build and deploy production-ready generative AI faster. AWS will soon be the first cloud provider to offer models from Luma AI and poolside. AWS will also add the latest Stability AI model in Amazon Bedrock and, through the new Amazon Bedrock Marketplace capability, is giving access to more than 100 popular, emerging, and specialized models, so customers can find the right set of models for their use case.Support for structured data and GraphRAG in Amazon Bedrock Knowledge Bases further expands how customers can leverage their data to deliver customized generative AI experiences.Amazon Bedrock provides customers with the broadest selection of fully managed models from leading AI companies, including AI21 Labs, Anthrop","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/a6O6zhRuVLz8AccNGi3ebg--~B/aD0zMjU7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/c14aa96444d6c042cc44e759ab0b9446","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/a6O6zhRuVLz8AccNGi3ebg--~B/aD0zMjU7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/c14aa96444d6c042cc44e759ab0b9446"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amazon-bedrock-empowers-customers-accelerate-175400553.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1366192091.USD","LU1046421795.USD","LU1868836591.USD","LU2461242641.AUD","LU0061474705.USD","LU1935042488.USD","LU2264538146.SGD","LU2023251221.USD","LU2326559502.SGD","GB00BDT5M118.USD","LU2087621335.USD","BK4507","AAQC","AMZN","IE00BJTD4N35.SGD","MAIA","LU0234572021.USD","LU0310799852.SGD","IE0009G5SDU7.USD","LU1244550221.USD","LU1791710582.SGD","LU2602419157.SGD","BK4596","IE0004091025.USD","LU2361044949.HKD","LU0276348264.USD","SG9999001077.SGD","LU0234570918.USD","LU1116320737.USD","LU1935042215.USD","LU2125154778.USD","SG9999018857.SGD","LU0345770993.USD","SG9999002232.USD","SG9999018865.SGD","SGXZ51526630.SGD","LU2247934214.USD","LU2462157665.USD","LU1803068979.SGD","LU1551013342.USD","LU1839511570.USD","LU2592432038.USD","LU0109392836.USD","BK4503","LU0417517546.SGD","LU0964807845.USD","BK4548","LU2552382058.USD","CUBI"],"gpt_icon":1},{"id":"2488943188","title":"Maia Biotechnology, Regeneron Expand Clinical Supply Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2488943188","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488943188?lang=en_us&edition=fundamental","pubTime":"2024-12-03 22:19","pubTimestamp":1733235599,"startTime":"0","endTime":"0","summary":"Maia Biotechnology  said Tuesday that it has amended a 2021 clinical supply deal with Regeneron  to cover the expansion of a phase 2 clinical trial evaluating investigational drug THIO in non-small cell lung cancer.According to the terms of the amended clinical supply agreement, Maia said Regeneron will provide its cancer drug Libtayo to treat all participants in the trial, including the additional patients in the expansion portion of the study.The expansion part of the trial will further evaluate the efficacy of THIO sequenced with Libtayo in advanced non-small cell lung cancer patients receiving third-line therapy who were resistant to previous checkpoint inhibitor treatments and chemotherapy, Maia said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0882574055.USD","LU0109394709.USD","LU2362540622.SGD","LU1974910355.USD","LU1917777945.USD","LU0114720955.EUR","BK4585","BK4139","LU2468319806.SGD","REGN","LU0058720904.USD","BK4588","LU0289739699.SGD","LU2089984988.USD","MAIA","LU0053666078.USD","LU0320765992.SGD","LU2362541273.HKD","LU2106854487.HKD","LU2362541513.USD","LU0823416689.USD","LU0889565916.HKD","LU2023250504.SGD"],"gpt_icon":0},{"id":"2488912487","title":"Maia Biotechnology Inc - Expects New Patient Enrollment to Begin Soon","url":"https://stock-news.laohu8.com/highlight/detail?id=2488912487","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488912487?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:17","pubTimestamp":1733231820,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUA2J0N9G:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU2362540622.SGD","LU0114720955.EUR","LU0823416689.USD","LU0053666078.USD","LU2089984988.USD","LU0109394709.USD","LU2023250504.SGD","LU0882574055.USD","LU2362541513.USD","LU1917777945.USD","LU1974910355.USD","REGN","BK4588","MAIA","BK4585","LU2468319806.SGD","LU0889565916.HKD","LU0058720904.USD","LU0289739699.SGD","LU2362541273.HKD","LU2106854487.HKD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2488912173","title":"Maia Biotechnology Announces Expansion of Clinical Supply Agreement With Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2488912173","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488912173?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:17","pubTimestamp":1733231820,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUA2J0N9G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"gpt_icon":0},{"id":"2488917330","title":"MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2488917330","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488917330?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:17","pubTimestamp":1733231820,"startTime":"0","endTime":"0","summary":"Expansion of 2021 clinical supply agreement for Phase 2 clinical trial. Next stage of trial to further assess efficacy of THIO in third line non-small cell lung cancer patients. MAIA expects new patient enrollment to begin soon in the expansion of THIO-101. THIO  is a first-in-class investigational telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer . Telomeres, along with the enzyme telomerase, play a fundamental role in the survival of cancer cells and their resistance to current therapies. The modified nucleotide 6-thio-2’-deoxyguanosine  induces telomerase-dependent telomeric DNA modification, DNA damage responses, and selective cancer cell death. THIO-damaged telomeric fragments accumulate in cytosolic micronuclei and activates both innate  a","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/hVRLq.FOnsnsghyRo3_eKQ--~B/aD0zODA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/894a52524dd3bbe408bbdb4419e82c09","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/hVRLq.FOnsnsghyRo3_eKQ--~B/aD0zODA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/894a52524dd3bbe408bbdb4419e82c09"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/maia-biotechnology-announces-expansion-clinical-131700223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4107","MAIA","BK4585","CPI","BK4139","LU0053666078.USD","L","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":66,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAIA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MAIA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1677038400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MAIA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MAIA","date":"2025-04-24","current":-2.608252,"percent":0.271084,"low":-5.555213,"twenty":-2.81441,"median":-2.188156,"eighty":-1.605596,"high":-0.77644,"avg":-2.232052,"sd":0.716722,"marketCap":60653993},"quantilePoints":[{"date":"2022-07-29","current":-4.130799,"twenty":-3.74477,"median":-3.33193,"eighty":-3.032982,"marketCap":61688243},{"date":"2022-08-05","current":-3.418592,"twenty":-4.327368,"median":-3.717719,"eighty":-3.321732,"marketCap":51052339},{"date":"2022-08-12","current":-3.539667,"twenty":-3.942776,"median":-3.513542,"eighty":-3.113768,"marketCap":52860442},{"date":"2022-08-19","current":-2.813217,"twenty":-3.757603,"median":-3.418592,"eighty":-3.057447,"marketCap":42011820},{"date":"2022-08-26","current":-2.813564,"twenty":-3.645074,"median":-3.16932,"eighty":-3.031815,"marketCap":41665794},{"date":"2022-09-02","current":-3.160645,"twenty":-3.562458,"median":-3.149236,"eighty":-2.973073,"marketCap":46805669},{"date":"2022-09-09","current":-3.035105,"twenty":-3.531121,"median":-3.079413,"eighty":-2.987843,"marketCap":44946565},{"date":"2022-09-16","current":-2.628947,"twenty":-3.505948,"median":-3.054305,"eighty":-2.874118,"marketCap":38931818},{"date":"2022-09-23","current":-2.400022,"twenty":-3.459888,"median":-3.035105,"eighty":-2.808995,"marketCap":35541688},{"date":"2022-09-30","current":-2.436946,"twenty":-3.337714,"median":-3.018069,"eighty":-2.628947,"marketCap":36088483},{"date":"2022-10-07","current":-2.481254,"twenty":-3.200415,"median":-2.976027,"eighty":-2.544762,"marketCap":36744637},{"date":"2022-10-14","current":-2.429561,"twenty":-3.170744,"median":-2.946489,"eighty":-2.506362,"marketCap":35979124},{"date":"2022-10-21","current":-2.326175,"twenty":-3.161577,"median":-2.817793,"eighty":-2.443001,"marketCap":34448097},{"date":"2022-10-28","current":-2.392637,"twenty":-3.156081,"median":-2.809698,"eighty":-2.436946,"marketCap":35432328},{"date":"2022-11-04","current":-2.673255,"twenty":-3.130168,"median":-2.80618,"eighty":-2.436946,"marketCap":39587972},{"date":"2022-11-11","current":-2.861595,"twenty":-3.092705,"median":-2.80618,"eighty":-2.443001,"marketCap":41539705},{"date":"2022-11-18","current":-2.59391,"twenty":-3.074979,"median":-2.80618,"eighty":-2.45489,"marketCap":37653909},{"date":"2022-11-25","current":-2.639153,"twenty":-3.06641,"median":-2.741401,"eighty":-2.463531,"marketCap":38310664},{"date":"2022-12-02","current":-2.782421,"twenty":-3.056964,"median":-2.74683,"eighty":-2.481254,"marketCap":40390385},{"date":"2022-12-09","current":-2.639153,"twenty":-3.048124,"median":-2.714557,"eighty":-2.485685,"marketCap":38310664},{"date":"2022-12-16","current":-2.571289,"twenty":-3.039919,"median":-2.704828,"eighty":-2.491357,"marketCap":37325532},{"date":"2022-12-23","current":-2.526046,"twenty":-3.035105,"median":-2.684395,"eighty":-2.489852,"marketCap":36668778},{"date":"2022-12-30","current":-2.646693,"twenty":-3.035105,"median":-2.669314,"eighty":-2.488344,"marketCap":38420123},{"date":"2023-01-06","current":-2.646693,"twenty":-3.028524,"median":-2.669314,"eighty":-2.494376,"marketCap":38420123},{"date":"2023-01-13","current":-3.008634,"twenty":-3.036309,"median":-2.678825,"eighty":-2.495884,"marketCap":43674156},{"date":"2023-01-20","current":-3.649345,"twenty":-3.053419,"median":-2.693672,"eighty":-2.500398,"marketCap":52974891},{"date":"2023-01-27","current":-3.381885,"twenty":-3.088275,"median":-2.710179,"eighty":-2.507838,"marketCap":49092379},{"date":"2023-02-03","current":-3.566626,"twenty":-3.137263,"median":-2.727137,"eighty":-2.510896,"marketCap":51774125},{"date":"2023-02-10","current":-3.332873,"twenty":-3.167896,"median":-2.752259,"eighty":-2.519723,"marketCap":48380895},{"date":"2023-02-17","current":-3.415817,"twenty":-3.245403,"median":-2.79807,"eighty":-2.525852,"marketCap":49584945},{"date":"2023-02-24","current":-3.566626,"twenty":-3.3193,"median":-2.80618,"eighty":-2.527554,"marketCap":51774125},{"date":"2023-03-03","current":-3.4686,"twenty":-3.350216,"median":-2.813564,"eighty":-2.531068,"marketCap":50351158},{"date":"2023-03-10","current":-3.016174,"twenty":-3.350216,"median":-2.827663,"eighty":-2.542251,"marketCap":43783616},{"date":"2023-03-17","current":-2.473263,"twenty":-3.346445,"median":-2.827663,"eighty":-2.542251,"marketCap":35902565},{"date":"2023-03-24","current":-2.399976,"twenty":-3.342675,"median":-2.81339,"eighty":-2.516804,"marketCap":38927270},{"date":"2023-03-31","current":-2.345739,"twenty":-3.337397,"median":-2.80618,"eighty":-2.495884,"marketCap":38047557},{"date":"2023-04-06","current":-2.284723,"twenty":-3.326087,"median":-2.805042,"eighty":-2.481254,"marketCap":37057881},{"date":"2023-04-14","current":-2.447433,"twenty":-3.292155,"median":-2.76734,"eighty":-2.461933,"marketCap":39697018},{"date":"2023-04-21","current":-2.393197,"twenty":-3.261993,"median":-2.739718,"eighty":-2.455007,"marketCap":38817306},{"date":"2023-04-28","current":-1.958672,"twenty":-3.24842,"median":-2.712368,"eighty":-2.44201,"marketCap":31769373},{"date":"2023-05-05","current":-2.318612,"twenty":-3.242387,"median":-2.695409,"eighty":-2.436946,"marketCap":37607553},{"date":"2023-05-12","current":-2.109365,"twenty":-3.242387,"median":-2.678825,"eighty":-2.414792,"marketCap":34746108},{"date":"2023-05-19","current":-1.988788,"twenty":-3.237189,"median":-2.669314,"eighty":-2.399985,"marketCap":33656034},{"date":"2023-05-26","current":-1.827752,"twenty":-3.208406,"median":-2.654233,"eighty":-2.392749,"marketCap":30930849},{"date":"2023-06-02","current":-2.069306,"twenty":-3.176442,"median":-2.646693,"eighty":-2.379637,"marketCap":35018627},{"date":"2023-06-09","current":-1.988788,"twenty":-3.162198,"median":-2.639153,"eighty":-2.33896,"marketCap":33656034},{"date":"2023-06-16","current":-1.851908,"twenty":-3.160645,"median":-2.635382,"eighty":-2.318791,"marketCap":31339627},{"date":"2023-06-23","current":-1.763338,"twenty":-3.153651,"median":-2.628947,"eighty":-2.307373,"marketCap":29840775},{"date":"2023-06-30","current":-1.731131,"twenty":-3.150302,"median":-2.609948,"eighty":-2.28744,"marketCap":29295738},{"date":"2023-07-07","current":-1.779442,"twenty":-3.141254,"median":-2.59768,"eighty":-2.242232,"marketCap":30113294},{"date":"2023-07-14","current":-1.755286,"twenty":-3.123249,"median":-2.586369,"eighty":-2.20532,"marketCap":29704516},{"date":"2023-07-21","current":-1.851908,"twenty":-3.111184,"median":-2.578041,"eighty":-2.067676,"marketCap":31339627},{"date":"2023-07-28","current":-1.859959,"twenty":-3.104623,"median":-2.56987,"eighty":-2.008112,"marketCap":31475886},{"date":"2023-08-04","current":-1.715028,"twenty":-3.097572,"median":-2.563748,"eighty":-1.974295,"marketCap":29023220},{"date":"2023-08-11","current":-1.557401,"twenty":-3.086713,"median":-2.556208,"eighty":-1.943698,"marketCap":28252239},{"date":"2023-08-18","current":-1.369309,"twenty":-3.075231,"median":-2.531381,"eighty":-1.90827,"marketCap":24840133},{"date":"2023-08-25","current":-1.437022,"twenty":-3.068706,"median":-2.525562,"eighty":-1.887815,"marketCap":26068491},{"date":"2023-09-01","current":-1.316644,"twenty":-3.064492,"median":-2.5071,"eighty":-1.866401,"marketCap":23884743},{"date":"2023-09-08","current":-1.32732,"twenty":-3.056964,"median":-2.495884,"eighty":-1.852819,"marketCap":24078428},{"date":"2023-09-15","current":-1.319779,"twenty":-3.048124,"median":-2.488344,"eighty":-1.851908,"marketCap":23941618},{"date":"2023-09-22","current":-1.161405,"twenty":-3.039919,"median":-2.477259,"eighty":-1.830989,"marketCap":21068624},{"date":"2023-09-29","current":-1.357487,"twenty":-3.035105,"median":-2.458182,"eighty":-1.797155,"marketCap":24625665},{"date":"2023-10-06","current":-1.89294,"twenty":-3.03346,"median":-2.451363,"eighty":-1.795545,"marketCap":34339121},{"date":"2023-10-13","current":-1.696859,"twenty":-3.026246,"median":-2.440654,"eighty":-1.781052,"marketCap":30782081},{"date":"2023-10-20","current":-1.772274,"twenty":-3.023715,"median":-2.436946,"eighty":-1.772274,"marketCap":32150173},{"date":"2023-10-27","current":-1.402736,"twenty":-3.020699,"median":-2.436946,"eighty":-1.772274,"marketCap":25446520},{"date":"2023-11-03","current":-1.538485,"twenty":-3.016174,"median":-2.424938,"eighty":-1.763338,"marketCap":27909087},{"date":"2023-11-10","current":-1.563529,"twenty":-3.013408,"median":-2.414792,"eighty":-1.758507,"marketCap":28319514},{"date":"2023-11-17","current":-1.098625,"twenty":-3.009008,"median":-2.400022,"eighty":-1.737573,"marketCap":19898915},{"date":"2023-11-24","current":-1.0945,"twenty":-3.00802,"median":-2.398918,"eighty":-1.715028,"marketCap":19824192},{"date":"2023-12-01","current":-0.93547,"twenty":-3.003917,"median":-2.393197,"eighty":-1.697272,"marketCap":16943754},{"date":"2023-12-08","current":-0.853009,"twenty":-2.993064,"median":-2.385536,"eighty":-1.662077,"marketCap":15450179},{"date":"2023-12-15","current":-0.830323,"twenty":-2.97455,"median":-2.366078,"eighty":-1.603306,"marketCap":15039276},{"date":"2023-12-22","current":-0.963534,"twenty":-2.967166,"median":-2.34235,"eighty":-1.566156,"marketCap":17452066},{"date":"2023-12-29","current":-1.159983,"twenty":-2.962735,"median":-2.332248,"eighty":-1.560368,"marketCap":21010254},{"date":"2024-01-05","current":-1.113209,"twenty":-2.959095,"median":-2.329178,"eighty":-1.540033,"marketCap":20163067},{"date":"2024-01-12","current":-1.319013,"twenty":-2.946198,"median":-2.318612,"eighty":-1.505189,"marketCap":23890693},{"date":"2024-01-19","current":-1.178692,"twenty":-2.917694,"median":-2.307373,"eighty":-1.461419,"marketCap":21349130},{"date":"2024-01-26","current":-1.262884,"twenty":-2.860841,"median":-2.292944,"eighty":-1.43018,"marketCap":22874067},{"date":"2024-02-02","current":-1.449978,"twenty":-2.853404,"median":-2.250825,"eighty":-1.422652,"marketCap":26262818},{"date":"2024-02-09","current":-1.337722,"twenty":-2.835718,"median":-2.238161,"eighty":-1.406928,"marketCap":24229568},{"date":"2024-02-16","current":-1.472372,"twenty":-2.835615,"median":-2.225173,"eighty":-1.406928,"marketCap":26668418},{"date":"2024-02-23","current":-1.37859,"twenty":-2.835204,"median":-2.173979,"eighty":-1.403205,"marketCap":24969793},{"date":"2024-03-01","current":-1.228539,"twenty":-2.828334,"median":-2.067947,"eighty":-1.384495,"marketCap":22251992},{"date":"2024-03-08","current":-1.312943,"twenty":-2.827663,"median":-2.013443,"eighty":-1.37859,"marketCap":23780755},{"date":"2024-03-15","current":-1.228539,"twenty":-2.827663,"median":-1.99684,"eighty":-1.369309,"marketCap":22251992},{"date":"2024-03-22","current":-1.819364,"twenty":-2.817793,"median":-1.988788,"eighty":-1.369309,"marketCap":32953332},{"date":"2024-03-28","current":-2.508838,"twenty":-2.81441,"median":-1.988788,"eighty":-1.373975,"marketCap":49607008},{"date":"2024-04-05","current":-2.225582,"twenty":-2.813286,"median":-2.013193,"eighty":-1.375141,"marketCap":44006217},{"date":"2024-04-12","current":-2.458256,"twenty":-2.807587,"median":-2.066589,"eighty":-1.376495,"marketCap":48606867},{"date":"2024-04-19","current":-2.040149,"twenty":-2.80618,"median":-2.065155,"eighty":-1.378239,"marketCap":40339679},{"date":"2024-04-26","current":-2.789592,"twenty":-2.80618,"median":-2.083954,"eighty":-1.37859,"marketCap":55158336},{"date":"2024-05-03","current":-3.278811,"twenty":-2.81441,"median":-2.154257,"eighty":-1.383204,"marketCap":64831627},{"date":"2024-05-10","current":-3.008179,"twenty":-2.829708,"median":-2.225173,"eighty":-1.384467,"marketCap":59480445},{"date":"2024-05-17","current":-2.706777,"twenty":-2.835307,"median":-2.225893,"eighty":-1.384495,"marketCap":64214183},{"date":"2024-05-24","current":-3.507054,"twenty":-2.863599,"median":-2.234604,"eighty":-1.387273,"marketCap":83199537},{"date":"2024-05-31","current":-4.040936,"twenty":-2.958014,"median":-2.241717,"eighty":-1.392304,"marketCap":95865084},{"date":"2024-06-07","current":-3.056015,"twenty":-2.984545,"median":-2.267774,"eighty":-1.39972,"marketCap":72499334},{"date":"2024-06-14","current":-3.488644,"twenty":-3.008452,"median":-2.292944,"eighty":-1.402924,"marketCap":82762794},{"date":"2024-06-21","current":-3.157269,"twenty":-3.016174,"median":-2.307373,"eighty":-1.403205,"marketCap":74901421},{"date":"2024-06-28","current":-3.06522,"twenty":-3.024981,"median":-2.311144,"eighty":-1.403205,"marketCap":72717706},{"date":"2024-07-05","current":-3.12045,"twenty":-3.037686,"median":-2.318701,"eighty":-1.404613,"marketCap":74027935},{"date":"2024-07-12","current":-3.516259,"twenty":-3.053559,"median":-2.33218,"eighty":-1.406806,"marketCap":83417909},{"date":"2024-07-15","current":-3.359776,"twenty":-3.057103,"median":-2.332214,"eighty":-1.406847,"marketCap":79705593},{"date":"2024-08-02","current":-2.853508,"twenty":-3.056559,"median":-2.332248,"eighty":-1.406887,"marketCap":67695161},{"date":"2024-08-09","current":-2.448494,"twenty":-3.051102,"median":-2.34235,"eighty":-1.406928,"marketCap":58086816},{"date":"2024-08-16","current":-2.426555,"twenty":-3.049827,"median":-2.33896,"eighty":-1.409608,"marketCap":68135554},{"date":"2024-08-23","current":-2.554268,"twenty":-3.042861,"median":-2.346358,"eighty":-1.412104,"marketCap":71721636},{"date":"2024-08-30","current":-2.383983,"twenty":-3.039749,"median":-2.352417,"eighty":-1.420092,"marketCap":66940193},{"date":"2024-09-06","current":-2.681981,"twenty":-3.036825,"median":-2.358441,"eighty":-1.424007,"marketCap":75307717},{"date":"2024-09-13","current":-2.767124,"twenty":-3.035105,"median":-2.377326,"eighty":-1.427844,"marketCap":77698439},{"date":"2024-09-20","current":-2.426555,"twenty":-3.030169,"median":-2.383983,"eighty":-1.429499,"marketCap":68135554},{"date":"2024-09-27","current":-2.222213,"twenty":-3.024981,"median":-2.383983,"eighty":-1.430561,"marketCap":62397823},{"date":"2024-10-04","current":-2.213699,"twenty":-3.01919,"median":-2.379637,"eighty":-1.432249,"marketCap":62158751},{"date":"2024-10-11","current":-2.247756,"twenty":-3.016174,"median":-2.371702,"eighty":-1.435374,"marketCap":63115039},{"date":"2024-10-18","current":-2.141328,"twenty":-3.012024,"median":-2.358441,"eighty":-1.437022,"marketCap":60126638},{"date":"2024-10-25","current":-2.188156,"twenty":-3.008884,"median":-2.346358,"eighty":-1.441989,"marketCap":61441534},{"date":"2024-10-31","current":-2.389927,"twenty":-3.008452,"median":-2.345739,"eighty":-1.447172,"marketCap":67107079},{"date":"2024-11-08","current":-2.83377,"twenty":-3.007134,"median":-2.34725,"eighty":-1.453828,"marketCap":79569822},{"date":"2024-11-15","current":-1.968024,"twenty":-3.002269,"median":-2.346358,"eighty":-1.460958,"marketCap":51049313},{"date":"2024-11-22","current":-2.076001,"twenty":-2.988805,"median":-2.341497,"eighty":-1.465271,"marketCap":53850185},{"date":"2024-11-29","current":-2.158258,"twenty":-2.975456,"median":-2.338036,"eighty":-1.469425,"marketCap":55983872},{"date":"2024-12-06","current":-1.933643,"twenty":-2.972266,"median":-2.332214,"eighty":-1.472826,"marketCap":50157496},{"date":"2024-12-13","current":-1.96294,"twenty":-2.967505,"median":-2.321643,"eighty":-1.479063,"marketCap":50917458},{"date":"2024-12-20","current":-1.992238,"twenty":-2.962612,"median":-2.316763,"eighty":-1.498022,"marketCap":51677420},{"date":"2024-12-27","current":-1.992238,"twenty":-2.961258,"median":-2.307373,"eighty":-1.503103,"marketCap":51677420},{"date":"2025-01-03","current":-2.041067,"twenty":-2.956932,"median":-2.307355,"eighty":-1.507276,"marketCap":52944024},{"date":"2025-01-10","current":-2.080131,"twenty":-2.941372,"median":-2.303098,"eighty":-1.515197,"marketCap":53957306},{"date":"2025-01-17","current":-1.972706,"twenty":-2.899372,"median":-2.296637,"eighty":-1.531004,"marketCap":51170779},{"date":"2025-01-24","current":-1.933643,"twenty":-2.87533,"median":-2.284723,"eighty":-1.538485,"marketCap":50157496},{"date":"2025-01-31","current":-1.875661,"twenty":-2.867606,"median":-2.264784,"eighty":-1.540033,"marketCap":48653485},{"date":"2025-02-07","current":-1.996671,"twenty":-2.860087,"median":-2.25627,"eighty":-1.544371,"marketCap":51792420},{"date":"2025-02-14","current":-1.885745,"twenty":-2.856098,"median":-2.247756,"eighty":-1.551399,"marketCap":48915063},{"date":"2025-02-21","current":-1.915998,"twenty":-2.84995,"median":-2.243914,"eighty":-1.558143,"marketCap":49699797},{"date":"2025-02-28","current":-1.986587,"twenty":-2.835718,"median":-2.237919,"eighty":-1.561594,"marketCap":51530842},{"date":"2025-03-07","current":-1.854501,"twenty":-2.835615,"median":-2.232622,"eighty":-1.563808,"marketCap":48104595},{"date":"2025-03-14","current":-1.703553,"twenty":-2.834917,"median":-2.225582,"eighty":-1.566156,"marketCap":44189105},{"date":"2025-03-21","current":-1.897628,"twenty":-2.832683,"median":-2.223693,"eighty":-1.572339,"marketCap":49223306},{"date":"2025-03-28","current":-2.073878,"twenty":-2.8282,"median":-2.216853,"eighty":-1.577368,"marketCap":48227321},{"date":"2025-04-04","current":-2.022985,"twenty":-2.827663,"median":-2.202461,"eighty":-1.578876,"marketCap":47043829},{"date":"2025-04-11","current":-1.857584,"twenty":-2.825689,"median":-2.188156,"eighty":-1.588437,"marketCap":43197478},{"date":"2025-04-17","current":-1.959369,"twenty":-2.817793,"median":-2.17779,"eighty":-1.602543,"marketCap":45564463},{"date":"2025-04-24","current":-2.608252,"twenty":-2.81441,"median":-2.188156,"eighty":-1.605596,"marketCap":60653993}],"updateTime":1745574523620}}}